The New York Times | Business Covers
2025
Art Direction: Zak Bickel
1) Not long ago, Novo Nordisk was Europe's most valuable company, its product was all over TikTok and Ozempic became shorthand for the multi-billion dollar industry of weight loss drugs. But its experienced a sharp reversal of fortunes. its share price more than 60 percent in the past year, its been overtaken by its biggest competitor Eli Lilly and recently the board ousted the CEO. This is the story of Novo Nordisk's fall from its lofty heights and investors' sky-high expectations.
2) U.S. officials are trying to crack down on DeepSeek and its American corporate ties. The Trump administration is reviewing military funding of the Chinese start-up, while a House select committee is opening an investigation into Nvidia because of reports that DeepSeek used restricted A.I. chips.
